Polycystic ovary syndrome screening: Difference between revisions
Aditya Ganti (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) |
||
| Line 10: | Line 10: | ||
*Serum prolactin levels | *Serum prolactin levels | ||
*Free androgen index | *Free androgen index | ||
===Criteria=== | |||
Two definitions are commonly used: | |||
*In 1990 a consensus workshop sponsored by the [[NIH]]/[[NICHD]] suggested that a patient has PCOS if she has | |||
**Signs of [[androgen]] excess (clinical or biochemical) | |||
**[[Oligoovulation]] | |||
**Other entities are excluded that would cause polycystic ovaries. | |||
*In 2003 a consensus workshop sponsored by [[ESHRE]]/[[ASRM]] in Rotterdam indicated PCOS to be present if 2 out of 3 criteria are met: <ref name="pmid14711538">{{cite journal |vauthors= |title=Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome |journal=Fertil. Steril. |volume=81 |issue=1 |pages=19–25 |year=2004 |pmid=14711538 |doi= |url=}}</ref> | |||
**[[Oligoovulation]] and/or [[anovulation]] | |||
**Excess androgen activity | |||
**Polycystic ovaries (by [[gynecologic ultrasound]]), and other causes of PCOS are excluded. | |||
The Rotterdam definition is wider, including many more patients, notably patients without androgen excess, whereas in the NIH/NICHD definition androgen excess is a | |||
==References== | ==References== | ||
Revision as of 15:03, 1 August 2017
|
Polycystic ovary syndrome Microchapters |
|
Differentiating Polycystic ovary syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Polycystic ovary syndrome screening On the Web |
|
American Roentgen Ray Society Images of Polycystic ovary syndrome screening |
|
Risk calculators and risk factors for Polycystic ovary syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
According to Royal College of Obstetricians and Gynaecologists (RCOG) thyroid function tests, serum prolactin levels, and a free androgen index are baseline screening tests recommended for women with suspected polycystic ovarian syndrome (PCOS).[1]
Screening
The Royal College of Obstetricians and Gynaecologists (RCOG) recommends the following baseline screening tests for women with suspected polycystic ovarian syndrome (PCOS): [1]
- Thyroid function tests
- Serum prolactin levels
- Free androgen index
Criteria
Two definitions are commonly used:
- In 1990 a consensus workshop sponsored by the NIH/NICHD suggested that a patient has PCOS if she has
- Signs of androgen excess (clinical or biochemical)
- Oligoovulation
- Other entities are excluded that would cause polycystic ovaries.
- In 2003 a consensus workshop sponsored by ESHRE/ASRM in Rotterdam indicated PCOS to be present if 2 out of 3 criteria are met: [2]
- Oligoovulation and/or anovulation
- Excess androgen activity
- Polycystic ovaries (by gynecologic ultrasound), and other causes of PCOS are excluded.
The Rotterdam definition is wider, including many more patients, notably patients without androgen excess, whereas in the NIH/NICHD definition androgen excess is a
References
- ↑ 1.0 1.1 Sheehan MT (2004). "Polycystic ovarian syndrome: diagnosis and management". Clin Med Res. 2 (1): 13–27. PMC 1069067. PMID 15931331.
- ↑ "Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome". Fertil. Steril. 81 (1): 19–25. 2004. PMID 14711538.